|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.80 EUR | +0.61% |
|
+0.48% | +7.25% |
| 05-12 | SARTORIUS VORZUEGE : Jefferies reiterates its Neutral rating | ZD |
| 05-07 | On the stockmarket, the pharmaceutical industry is wary of FDA's new strongman |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions on site
| Capitalization | 14.43B 16.14B 13.47B 12.14B 22.53B 1,377B 25.19B 158B 61.65B 626B 60.45B 59.19B 2,341B | P/E ratio 2025 * |
71.4x | P/E ratio 2026 * | 53.5x |
|---|---|---|---|---|---|
| Enterprise value | 18.03B 20.18B 16.84B 15.17B 28.16B 1,721B 31.48B 197B 77.05B 782B 75.55B 73.98B 2,926B | EV / Sales 2025 * |
5.04x | EV / Sales 2026 * | 4.52x |
| Free-Float |
35.68% | Yield 2025 * |
0.33% | Yield 2026 * | 0.41% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sartorius AG
More recommendations
More press releases
More news
| 1 day | +0.61% | ||
| 1 week | +0.48% | ||
| Current month | +1.63% | ||
| 1 month | +10.43% | ||
| 3 months | -5.76% | ||
| 6 months | +7.55% | ||
| Current year | +7.25% |
| 1 week | 224.5 |  | 237.5 |
| 1 month | 208.7 | | 239.4 |
| Current year | 166.05 | | 292 |
| 1 year | 166.05 | | 292 |
| 3 years | 166.05 | | 471.7 |
| 5 years | 166.05 | | 631.6 |
| 10 years | 37.5 | | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 2004-12-31 | |
Florian Funck
DFI | Director of Finance/CFO | 54 | 2024-03-31 |
Volker Niebel
COO | Chief Operating Officer | 68 | 2000-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 61 | 2002-08-31 |
Lothar Kappich
CHM | Chairman | 68 | 2017-07-08 |
Petra Kirchhoff
BRD | Director/Board Member | 56 | 2010-09-30 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.78% | 0 M€ | +55.76% | - | |
| 0.78% | 1 M€ | 0.00% | - | |
| 0.75% | 962 M€ | -.--% | - | |
| 0.75% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.61% | +0.48% | -14.04% | -33.37% | 16.08B | ||
| +1.30% | -7.93% | -21.86% | -67.63% | 2.26B | ||
| +1.30% | -1.87% | -17.26% | - | 1.37B | ||
| +0.28% | +0.21% | -20.71% | -27.44% | 1.16B | ||
| -1.59% | -1.75% | -40.71% | +106.49% | 1.14B | ||
| +1.54% | +2.44% | -7.93% | +22.39% | 887M | ||
| +0.17% | +4.11% | +0.24% | -35.19% | 864M | ||
| -0.78% | +2.95% | -13.17% | -48.34% | 779M | ||
| +0.95% | -1.44% | -18.38% | -43.42% | 467M | ||
| -0.13% | +14.53% | -47.36% | -64.55% | 327M | ||
| Average | +0.37% | +0.87% | -20.12% | -21.23% | 2.53B | |
| Weighted average by Cap. | +0.57% | -0.18% | -16.20% | -28.78% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.58B 4.01B 3.34B 3.01B 5.59B 342B 6.25B 39.1B 15.3B 155B 15B 14.69B 581B | 3.92B 4.39B 3.66B 3.3B 6.13B 375B 6.85B 42.84B 16.77B 170B 16.44B 16.1B 637B |
| Net income | 228M 255M 213M 192M 356M 21.76B 398M 2.49B 974M 9.89B 955M 935M 37B | 320M 358M 299M 269M 500M 30.58B 559M 3.5B 1.37B 13.9B 1.34B 1.31B 52B |
| Net Debt | 3.6B 4.03B 3.37B 3.03B 5.63B 344B 6.29B 39.36B 15.4B 156B 15.1B 14.79B 585B | 3.31B 3.7B 3.09B 2.78B 5.17B 316B 5.78B 36.13B 14.14B 144B 13.86B 13.58B 537B |
More financial data
* Estimated data
Employees
13,573
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-05-16 | 230.80 € | +0.61% | 93,071 |
| 25-05-15 | 229.40 € | -1.42% | 78,485 |
| 25-05-14 | 232.70 € | -0.17% | 82,062 |
| 25-05-13 | 233.10 € | +0.47% | 73,916 |
| 25-05-12 | 232.00 € | +1.00% | 123,833 |
Delayed Quote Xetra, May 16, 2025 at 11:36 am
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
230.80EUR
Average target price
268.00EUR
Spread / Average Target
+16.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition